Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 1, 2003
Grant Date -
N/A
app pub date -
Mar 10, 1999
filing date -
Mar 11, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Novel methods of medical treatment and/or inhibition of development of diseases are disclosed for diseases that are sensitive to androgenic or estrogenic activity. The treatments utilize inhibitors of type 5 and/or type 3 17.beta.-hydroxysteroid dehydrogenase. Novel inhibitors of type 5 17.beta.-hydroxysteroid dehydrogenase are also disclosed, as are novel inhibitors of type 3 17.beta.-hydroxysteroid dehydrogenase.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully